News + Filings Transactions
|
Harris Taylor C.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/18/2023 | CUTERA INC | CUTR | Grant | Common Stock | 249.3k | $0.00 | $0 | | 08/18/2023 |
| 08/18/2023 | CUTERA INC | CUTR | Grant | Stock Option (Right to Buy) | 735.3k | $11.02 | $8.1M | | 08/18/2023 |
| 06/15/2023 | PROCEPT BioRobotics Corp | PRCT | Grant | Common Stock | 2.7k | $0.00 | $0 | | 06/15/2023 |
| 06/15/2023 | PROCEPT BioRobotics Corp | PRCT | Grant | Stock Option (Right to Buy) | 4.9k | $35.09 | $170.7k | | 06/15/2023 |
| 05/19/2023 | CUTERA INC | CUTR | Grant | Stock Option (Right to Buy) | 25.3k | $16.84 | $426.5k | | 05/19/2023 |
| 06/07/2022 | PROCEPT BioRobotics Corp | PRCT | Grant | Common Stock | 2k | $37.48 | $75k | | 06/07/2022 |
| 06/07/2022 | PROCEPT BioRobotics Corp | PRCT | Grant | Common Stock | 4.2k | $38.85 | $163.4k | | 06/07/2022 |
| 09/17/2021 | PROCEPT BioRobotics Corp | PRCT | Conversion | Series G Convertible Preferred Stock | 3.9k | $0.00 | $0 | | 09/17/2021 |
| 09/17/2021 | PROCEPT BioRobotics Corp | PRCT | Conversion | Series E Convertible Preferred Stock | 31.2k | $0.00 | $0 | | 09/17/2021 |
| 09/17/2021 | PROCEPT BioRobotics Corp | PRCT | Purchase | Common Stock | 10k | $25.00 | $250k | | 09/17/2021 |
| 09/17/2021 | PROCEPT BioRobotics Corp | PRCT | Conversion | Common Stock | 35.1k | $0.00 | $0 | | 09/17/2021 |
| 09/14/2021 | PROCEPT BioRobotics Corp | PRCT | Grant | Stock Option (Right to Buy) | 10.3k | $25.00 | $257.7k | | 09/14/2021 |
| 11/17/2020 | MyoKardia, Inc. | MYOK | Other | Common Stock | 42.6k | $0.00 | $0 | | 11/17/2020 |
| 11/17/2020 | MyoKardia, Inc. | MYOK | Disposition | Stock Option (Right to buy) | 100k | $48.50 | $4.8M | | 11/17/2020 |
| 11/17/2020 | MyoKardia, Inc. | MYOK | Disposition | Stock Option (Right to buy) | 49.4k | $40.11 | $2M | | 11/17/2020 |
| 11/17/2020 | MyoKardia, Inc. | MYOK | Disposition | Stock Option (Right to buy) | 46.1k | $70.40 | $3.2M | | 11/17/2020 |
| 04/06/2020 | MyoKardia, Inc. | MYOK | Sale | Common Stock | 1.3k | $46.99 | $61.3k | | 04/04/2020 |
| 04/04/2020 | MyoKardia, Inc. | MYOK | Exercise | Restricted Stock Units | 3.8k | $0.00 | $0 | | 04/04/2020 |
| 02/14/2020 | MyoKardia, Inc. | MYOK | Grant | Stock Option (Right to Buy) | 46.1k | $70.40 | $3.2M | | 02/14/2020 |
| 02/14/2020 | MyoKardia, Inc. | MYOK | Grant | Restricted Stock Units | 14.9k | $0.00 | $0 | | 02/14/2020 |
| 01/06/2020 | MyoKardia, Inc. | MYOK | Sale | Common Stock | 1.7k | $68.45 | $115.2k | | 01/06/2020 |
| 01/01/2020 | MyoKardia, Inc. | MYOK | Exercise | Restricted Stock Units | 4.2k | $0.00 | $0 | | 01/01/2020 |
| 04/05/2019 | MyoKardia, Inc. | MYOK | Exercise | Restricted Stock Units | 3.8k | $0.00 | $0 | | 04/05/2019 |
| 04/05/2019 | MyoKardia, Inc. | MYOK | Sale | Common Stock | 1.3k | $53.30 | $70.6k | | 04/05/2019 |
| 02/08/2019 | MyoKardia, Inc. | MYOK | Grant | Stock Option (Right to Buy) | 49.4k | $40.11 | $2M | | 02/08/2019 |
| 02/08/2019 | MyoKardia, Inc. | MYOK | Grant | Restricted Stock Units | 17k | $0.00 | $0 | | 02/08/2019 |
| 04/04/2018 | MyoKardia, Inc. | MYOK | Grant | Stock Option (Right to Buy) | 100k | $48.50 | $4.8M | | 04/04/2018 |
| 04/04/2018 | MyoKardia, Inc. | MYOK | Grant | Restricted Stock Units | 15k | $0.00 | $0 | | 04/04/2018 |
| 03/01/2017 | Zeltiq Aesthetics Inc | ZLTQ | Payment of Exercise | Common Stock | 5.3k | $55.48 | $294.4k | | 03/01/2017 |
| 01/18/2017 | Zeltiq Aesthetics Inc | ZLTQ | Grant | | 11.6k | $0.00 | $0 | | 01/18/2017 |
| 01/18/2017 | Zeltiq Aesthetics Inc | ZLTQ | Grant | Stock Option (right to buy) | 22.2k | $40.89 | $909.1k | | 01/18/2017 |
| 10/15/2014 | THORATEC CORP | THOR | Payment of Exercise | Common Stock | 640 | $25.78 | $16.5k | | 10/15/2014 |
| 06/16/2014 | THORATEC CORP | THOR | Payment of Exercise | Common Stock | 653 | $33.36 | $21.8k | | 06/16/2014 |
| 03/17/2014 | THORATEC CORP | THOR | Grant | | 11.1k | $0.00 | $0 | | 03/17/2014 |
| 03/17/2014 | THORATEC CORP | THOR | Payment of Exercise | Common Stock | 940 | $35.00 | $32.9k | | 03/17/2014 |
|
|